EANO guidelines for the diagnosis and treatment of meningiomas

Roland Goldbrunner1, Giuseppe Minniti2, Matthias Preusser3

  • 1Center of Neurosurgery, Department of General Neurosurgery, University of Cologne, Cologne, Germany.

The Lancet. Oncology
|September 7, 2016
PubMed

Insights

Meningiomas, common brain tumors, have limited evidence for treatment guidelines. The European Association of Neuro-Oncology (EANO) developed evidence-based recommendations for diagnosis and management of these intracranial tumors.

Area of Science:

  • Neuro-oncology
  • Neurosurgery
  • Radiation Oncology

Background:

  • Meningiomas are the most frequent primary intracranial tumors.
  • Limited high-level evidence exists for meningioma diagnosis and treatment recommendations compared to other brain tumors.
  • The European Association of Neuro-Oncology (EANO) established a task force to address this gap.

Purpose of the Study:

  • To assess the scientific literature on meningiomas.
  • To develop evidence-based recommendations for the diagnosis and treatment of meningiomas for health professionals.
  • To provide a framework for managing these common intracranial tumors.

Main Methods:

  • Comprehensive review of the scientific literature on meningiomas.
  • Expert consensus and evidence grading by the EANO meningioma task force.
  • Formulation of clinical recommendations based on the assessed evidence.

Main Results:

  • Magnetic Resonance Imaging (MRI) is crucial for provisional meningioma diagnosis.
  • Definitive diagnosis requires surgical tissue for histological classification, grading, and molecular profiling.
  • Observation is often the best approach for elderly patients; surgical resection or radiotherapy are standard treatments when necessary.
  • Novel treatment strategies combining surgery and radiotherapy, as well as experimental pharmacotherapies, are under investigation.

Conclusions:

  • Evidence-based recommendations for meningioma diagnosis and treatment are now available.
  • Management strategies include observation, surgery, radiotherapy, and emerging pharmacotherapies.
  • Further research is needed to advance treatment options, particularly for refractory meningiomas.

Related Concept Videos

Cranial and Spinal Meninges01:19

Cranial and Spinal Meninges

The cranial and spinal meninges are complex protective structures surrounding the central nervous system (CNS), consisting of the brain and spinal cord. These meninges consist of the dura mater, the arachnoid mater, and the pia mater. They protect the CNS, provide structural support, and aid in circulating cerebrospinal fluid (CSF).
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...